Industry

BostonGene Announces Strategic Alliance with the Massachusetts General Hospital Cancer Center

WALTHAM, Mass.–(BUSINESS WIRE)–BostonGene Corporation today announced a Master Agreement with Massachusetts General Hospital Cancer Center, a member of the Mass General Brigham (MGB) healthcare system, to collaborate on multiple research projects. The alliance aims to support clinical research utilizing BostonGene’s CLIA-certified and CAP-accredited high complexity molecular laboratory and advanced computational algorithms to identify and validate … [Read more…]

Medidata Experts to Discuss the Evolution of Clinical Data Management at SCDM Annual Conference

Company Innovators to Lead Sessions on Regulatory Affairs, Imaging, Risk-Based Quality Management, and Medidata Clinical Cloud Technology NEW YORK–(BUSINESS WIRE)–Experts from Medidata, a Dassault Systèmes company, will be chairing sessions on promoting consensus between regulators and the industry, imaging quality control, and presenting a product showcase on Medidata Clinical Cloud at the Society for Clinical … [Read more…]

First Patient Enrolled in AMIHOT III Trial Investigating ZOLL’s Supersaturated Oxygen Therapy in Heart Attack Patients

Study Evaluates the Effectiveness of TherOx Supersaturated Oxygen (SSO2) Therapy in Patients Presenting with Acute Anterior Myocardial Infarction with Successful Reperfusion Compared to Standard Therapy CHELMSFORD, Mass.–(BUSINESS WIRE)–ZOLL® Medical Corporation, an Asahi Kasei company that manufactures medical devices and related software solutions, announced today that the first patient has enrolled in the AMIHOT III post-approval … [Read more…]

BCV Announces First-In-Human Cases with GECKO System Aimed at Increased Procedural Speed and Reduced Complication in Neurovascular Procedures

REIMS, France–(BUSINESS WIRE)–BCV announces a major step in the development and evaluation of steerable mechatronic guidewires for stroke treatment – the GECKO System. The first-in-human case was conducted by Michel Piotin, MD, PhD, head of Interventional neuroradiology at Foundation Rothschild Hospital in Paris, France. Worldwide each year more than 12.2 million people suffer a stroke.1 … [Read more…]

Arpeggio Biosciences Raises $17 Million in Series A Funding Led by Builders VC

New capital will support ongoing development of their drug pipeline targeting transcriptional mechanisms in disease Arpeggio’s technology isolates a drug’s effect on entire transcriptomes and has identified new modulators of hard-to-drug proteins like transcription factors To date, Arpeggio has contracted with more than 40 pharmaceutical companies to assess the impact of diverse classes of molecules … [Read more…]

Exscientia to Present at Upcoming Investor Conferences in September

OXFORD, England–(BUSINESS WIRE)–Exscientia (Nasdaq: EXAI) today announced that Company management will participate in the following investor conferences in September: Morgan Stanley Annual Global Healthcare Conference: Date: Wednesday, September 14, 2022 Time: 3:35 p.m. BST / 10:35 a.m. EST Location: New York, New York Participants: Ben Taylor, CFO & Chief Strategy Officer and Dave Hallett, Chief … [Read more…]

CONNECT1 Study Published in Journal of Allergy and Clinical Immunology: In Practice Evaluates the Potential of ProAir® Digihaler® (albuterol sulfate) Inhalation Powder and Digihaler System to Help Improve Asthma Management

Results from the study showed adults and children aged 13 and older with uncontrolled asthma using the ProAir Digihaler and its integrated system had 85.3% higher odds of improving their asthma control after three months compared with those using standard of care albuterol inhalers Physicians reported more interactions with patients on poor inhaler technique based … [Read more…]

AMC Research Enrolling Patients near Charlotte, NC for Clinical Trial of Promising New Investigational Treatment for Alzheimer’s Disease

Individuals with memory problems encouraged to learn more about study MATTHEWS, N.C.–(BUSINESS WIRE)–AMC Research is initiating a clinical trial for a promising new investigational treatment for Alzheimer’s disease (AD) in Matthews, N.C. The Phase I study will determine the safety and tolerability of a single intravenous (IV) dose and multiple IV doses of ACU193. We … [Read more…]

Pear Therapeutics to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference

BOSTON–(BUSINESS WIRE)–Pear Therapeutics, Inc. (Nasdaq: PEAR), the leader in developing and commercializing software-based medicines called prescription digital therapeutics (PDTs), today announced the company will participate in the Morgan Stanley 20th Annual Global Healthcare Conference taking place September 12-14, 2022 in New York City. Corey McCann, M.D., Ph.D., President and CEO, will participate in a fireside … [Read more…]

Bristol Myers Squibb Employees to Relay Nearly 3,000 Miles Cross-Country Aspiring to Raise Over $1 Million for the V Foundation for Cancer Research

More than 126 employees to ride in the company’s annual Coast 2 Coast 4 Cancer ride through towns and cities between the Oregon Coast and the New Jersey shore PRINCETON, N.J.–(BUSINESS WIRE)–$BMY #C2C4C–Bristol Myers Squibb employees will embark on a cross-country bike ride from the coast of Oregon to honor loved ones who have been … [Read more…]